Report Detail
Global (United States, European Union and China) Huntingtons Disease Therapeutics Market Research Report 2019-2025
- RnM3578849 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.
In 2019, the market size of Huntingtons Disease Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Huntingtons Disease Therapeutics.
This report studies the global market size of Huntingtons Disease Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Huntingtons Disease Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Auspex Pharmaceuticals
Alnylam Pharmaceuticals
Intellect Neurosciences Incorporation
H. Lundbeck
Prana Biotechnology Limited
Raptor Pharmaceuticals
Sangamo Biosciences
Teva Pharmaceutical Industries
Trophos SA
Valeant Pharmaceuticals International
Vertex Pharmaceuticals
Roche
Market Segment by Product Type
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Market Segment by Application
Hosptial
Clinic
Research
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Huntingtons Disease Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Huntingtons Disease Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Huntingtons Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Huntingtons Disease Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Antidopaminergics
- 1.3.3 Anticonvulsants
- 1.3.4 Antipsychotics
- 1.3.5 Antidepressants
- 1.4 Market Segment by Application
- 1.4.1 Global Huntingtons Disease Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Hosptial
- 1.4.3 Clinic
- 1.4.4 Research
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Huntingtons Disease Therapeutics Market Size
- 2.1.1 Global Huntingtons Disease Therapeutics Revenue 2014-2025
- 2.1.2 Global Huntingtons Disease Therapeutics Sales 2014-2025
- 2.2 Huntingtons Disease Therapeutics Growth Rate by Regions
- 2.2.1 Global Huntingtons Disease Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Huntingtons Disease Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Huntingtons Disease Therapeutics Sales by Manufacturers
- 3.1.1 Huntingtons Disease Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Huntingtons Disease Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Huntingtons Disease Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Huntingtons Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Huntingtons Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Huntingtons Disease Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Huntingtons Disease Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Huntingtons Disease Therapeutics Market
- 3.6 Key Manufacturers Huntingtons Disease Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Antidopaminergics Sales and Revenue (2014-2019)
- 4.1.2 Anticonvulsants Sales and Revenue (2014-2019)
- 4.1.3 Antipsychotics Sales and Revenue (2014-2019)
- 4.1.4 Antidepressants Sales and Revenue (2014-2019)
- 4.2 Global Huntingtons Disease Therapeutics Sales Market Share by Type
- 4.3 Global Huntingtons Disease Therapeutics Revenue Market Share by Type
- 4.4 Huntingtons Disease Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Huntingtons Disease Therapeutics Sales by Application
6 United States
- 6.1 United States Huntingtons Disease Therapeutics Breakdown Data by Company
- 6.2 United States Huntingtons Disease Therapeutics Breakdown Data by Type
- 6.3 United States Huntingtons Disease Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Huntingtons Disease Therapeutics Breakdown Data by Company
- 7.2 European Union Huntingtons Disease Therapeutics Breakdown Data by Type
- 7.3 European Union Huntingtons Disease Therapeutics Breakdown Data by Application
8 China
- 8.1 China Huntingtons Disease Therapeutics Breakdown Data by Company
- 8.2 China Huntingtons Disease Therapeutics Breakdown Data by Type
- 8.3 China Huntingtons Disease Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Company
- 9.2 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Type
- 9.3 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Application
- 9.4 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Huntingtons Disease Therapeutics Sales by Countries
- 9.4.2 Rest of World Huntingtons Disease Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Auspex Pharmaceuticals
- 10.1.1 Auspex Pharmaceuticals Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.1.4 Huntingtons Disease Therapeutics Product Introduction
- 10.1.5 Auspex Pharmaceuticals Recent Development
- 10.2 Alnylam Pharmaceuticals
- 10.2.1 Alnylam Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.2.4 Huntingtons Disease Therapeutics Product Introduction
- 10.2.5 Alnylam Pharmaceuticals Recent Development
- 10.3 Intellect Neurosciences Incorporation
- 10.3.1 Intellect Neurosciences Incorporation Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.3.4 Huntingtons Disease Therapeutics Product Introduction
- 10.3.5 Intellect Neurosciences Incorporation Recent Development
- 10.4 H. Lundbeck
- 10.4.1 H. Lundbeck Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.4.4 Huntingtons Disease Therapeutics Product Introduction
- 10.4.5 H. Lundbeck Recent Development
- 10.5 Prana Biotechnology Limited
- 10.5.1 Prana Biotechnology Limited Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.5.4 Huntingtons Disease Therapeutics Product Introduction
- 10.5.5 Prana Biotechnology Limited Recent Development
- 10.6 Raptor Pharmaceuticals
- 10.6.1 Raptor Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.6.4 Huntingtons Disease Therapeutics Product Introduction
- 10.6.5 Raptor Pharmaceuticals Recent Development
- 10.7 Sangamo Biosciences
- 10.7.1 Sangamo Biosciences Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.7.4 Huntingtons Disease Therapeutics Product Introduction
- 10.7.5 Sangamo Biosciences Recent Development
- 10.8 Teva Pharmaceutical Industries
- 10.8.1 Teva Pharmaceutical Industries Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.8.4 Huntingtons Disease Therapeutics Product Introduction
- 10.8.5 Teva Pharmaceutical Industries Recent Development
- 10.9 Trophos SA
- 10.9.1 Trophos SA Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.9.4 Huntingtons Disease Therapeutics Product Introduction
- 10.9.5 Trophos SA Recent Development
- 10.10 Valeant Pharmaceuticals International
- 10.10.1 Valeant Pharmaceuticals International Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
- 10.10.4 Huntingtons Disease Therapeutics Product Introduction
- 10.10.5 Valeant Pharmaceuticals International Recent Development
- 10.11 Vertex Pharmaceuticals
- 10.12 Roche
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Huntingtons Disease Therapeutics Sales Channels
- 11.2.2 Huntingtons Disease Therapeutics Distributors
- 11.3 Huntingtons Disease Therapeutics Customers
12 Market Forecast
- 12.1 Global Huntingtons Disease Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Huntingtons Disease Therapeutics Sales Forecast by Type
- 12.3 Global Huntingtons Disease Therapeutics Sales Forecast by Application
- 12.4 Huntingtons Disease Therapeutics Forecast by Regions
- 12.4.1 Global Huntingtons Disease Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Huntingtons Disease Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Huntingtons Disease Therapeutics. Industry analysis & Market Report on Huntingtons Disease Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Huntingtons Disease Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Huntingtons Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
